Abiopharma

🔍 Yates Charles L. (Executive)

Company: Commercial Bancgroup, Inc. (CBK)

Report Date: 2026-02-13

Detailed Transactions and Holdings:

• Sold 41,475 shares of Common Stock (Direct)
  Date: 2026-02-13 | Code: W | equity_swap_involved: 0 | transaction_form_type: 5 | Footnotes: F1
• Sold 31,106 shares of Common Stock (Direct)
  Date: 2026-02-13 | Code: W | equity_swap_involved: 0 | transaction_form_type: 5 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-02-13 | Code: H | shares_owned_after: 79,284.50 | Footnotes: F2

Footnotes:

• F1: The reported disposition occurred in connection with the passing of Peggy C. Smith on February 13, 2026.
• F2: 469 of these shares represent an award of restricted stock units (collectively, the "RSUs" and each, an "RSU") granted pursuant to the Commercial Bancgroup, Inc. 2025 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest 100% on the date of the Issuer's 2026 annual meeting of shareholders.
• F3: Previously, the Reporting Person had inadvertently under reported his beneficial ownership by 1.25 shares of Issuer's common stock.